Your Health & Safety Is Important to Us: Learn More Here

May 10 - 12, 2021 | Las Vegas

Keynote Presentations

Mon., Aug. 17, 2:30 PM - 2:50 PM

Biotech Investing Post-Covid-19 Pandemic

Join John McCamant of the Medical Technology Stock Letter, who's editors have more than 70 years of combined experience in biotech investing, as he discusses how post-pandemic biotech stocks are poised to become the premier growth sector for the next decade. Biotech investing is the perfect nexus of wealth, health, and technology. Biotech will be a major part of the solution to Covid-19—as it has already demonstrated—with over 100 new trials starting recently for treatments, vaccines, and diagnostic tools.

speaker photo BIOTECH
John McCamant


Medical Technology Stock Letter

Ready to #InvestSmarter?

This interactive event is a unique experience that will connect you with world-class financial experts who will give you clear, concise, and carefully crafted advice to steer you safely through the current environment. But that’s not all, you can also ask them questions and get answers in real time.

Register Now